Medline Inc

MDLN

Market cap $39.4B

Did you know that the largest initial public offering in 2025 was a boring medical supply company based in Chicago? Medline looks primed and ready to continue delivering on its history of rapid, profitable sales growth These 10 Stocks Could Mint the Next Wave of Millionaires ›

NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results.

Medline Industries (MDLN) earns a buy rating due to its robust vertically integrated model and scale-driven logistics advantages. MDLN's private label strategy enables margin expansion as contract wins accelerate, with signed FY2025 Prime Vendor contracts already doubling historical run rates. The company's logistics moat and cross-selling drive a virtuous cycle of market share gains and higher profitability, supporting durable growth.

Medline Inc. (MDLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Several analysts initiated coverage on Medline Inc. (NASDAQ: MDLN) on Monday, one of the largest providers of medical-surgical products and supply chain solutions.

Brokerages began coverage of Medline with largely bullish ratings on Monday, betting on supply chain strength and brand penetration, following the firm's upsized U.S. initial public offering in December - the biggest globally in 2025.

NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco, Calif., on Tuesday, January 13, 2026, at 3:00 pm Pacific Time.

As the year winds down, many investors are positioning themselves for 2026 and beyond.

Two sizable IPOs priced this week, joined by seven SPACs. Ten IPOs and eight SPACs submitted initial filings. No IPOs are currently scheduled in the week ahead, although smaller issuers may join the calendar throughout the week.

Here are some of the major companies whose stocks moved on the week's news.